Keyphrases
Herpes Simplex Virus
100%
Herpes Simplex Virus Infection
100%
Naked Mole-rat
100%
Replication-competent
100%
Antiviral Drug Development
100%
Hyaluronan Synthase
100%
Lung Adenocarcinoma Cells
100%
Herpes Simplex Virus Vector
60%
Oncolytic Herpes Simplex Virus (oHSV)
25%
Oncosuppression
25%
Transgene Expression
20%
Expression Effects
20%
Cancer Resistance
20%
Epidermolysis Bullosa
20%
Glioma Cells
20%
Talimogene Laherparepvec (T-VEC)
20%
Novel Vectors
20%
Unique mutation
20%
Rare Genetic Disease
20%
Viral Reactivation
14%
Product Gene
14%
Neonatal Herpes
14%
Genital Lesions
14%
Viral Shedding
14%
Herpes Encephalitis
14%
Asymptomatic Shedding
14%
Herpes Simplex Virus 2 (HSV-2)
14%
Herpes Keratitis
14%
Nucleoside Analogues
14%
Orofacial
14%
Latent Infection
14%
Antiviral Treatment
14%
Global Seroprevalence
14%
Herpesvirus Infection
14%
New Therapies
14%
Antiviral Response
14%
Infection Reactivation
14%
Herpes
14%
Virus Strains
14%
Adult Population
14%
Viral Transmission
14%
Recurrent Lesions
14%
Extracellular Proteoglycan
12%
Oncolysis
12%
Lung-other
12%
Medicine and Dentistry
Herpes Simplex Virus
100%
Hyaluronate Synthetase
100%
Nevus
100%
Transgene
100%
Decorin
100%
Virus Vector
42%
Talimogene Laherparepvec
28%
Oncolytic Herpes Virus
25%
Antiviral Therapy
22%
Genetic Disorder
14%
Glioma Cell
14%
Epidermolysis Bullosa Dystrophica
14%
Cancer Resistance
14%
Lung Adenocarcinoma Cell Line
12%
Proteoglycan
12%
Seroprevalence
11%
Nucleoside Analogue
11%
Herpes Simplex Virus 2
11%
Virus Strain
11%
Herpes Simplex Keratitis
11%
Virus Shedding
11%
Herpes Simplex
11%
Herpes Simplex Encephalitis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Herpes Simplex Virus
100%
Oncolytic Herpes Virus
25%
Cancer Mortality
12%
Proteoglycan
12%
Virus Strain
11%
Herpes Simplex Keratitis
11%
Herpes Simplex Virus 2
11%
Herpes Simplex
11%
Seroprevalence
11%
Herpes Simplex Encephalitis
11%